Back to discover
Disease

Sepsis

Late-stage therapeutic developmentActively researchedRising momentum
50
Publications
24
Clinical trials
12
Related conditions
3
Related proteins
2025
Latest publication
Current focus
P05231 biologyQ9nzq7 biologyTherapeutic developmentInflammation & immunity
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

The role of trained immunity in sepsis.

Research2024-08-15Frontiers in immunology

Post-sepsis psychiatric disorder: Pathophysiology, prevention, and treatment.

Research2024-02-21Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Research Highlights2View
Clinical Milestones9View all 9
+1 more in the activity timeline below
Activity timeline11

Clinical trials

17 sponsors · 4 new · 4 completed in the last 12 months (net +4)

The current development programme across all trial phases.

Clinical programme
24
All trials
6
Active
18
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

50 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20112025
Most influential
Recent publications
Major themes8
  • Sepsis31
  • Cell-Free Nucleic Acids2
  • Extracellular Traps2
  • High-Throughput Nucleotide Sequencing2
  • Immunity, Innate2
  • Inflammation2
  • Shock, Septic2
  • Acute Kidney Injury1
Leading journals6
  • Frontiers in immunology9
  • Critical care medicine3
  • Critical care (London, England)2
  • Frontiers in cellular and infection microbiology2
  • International journal of molecular sciences2
  • Lancet (London, England)2
Leading researchers8
  • Angus DC5
  • Alhazzani W3
  • Annane D3
  • Dellinger RP3
  • Levy MM3
  • Li J3
  • Machado FR3
  • Seymour CW3
Affiliations (unnormalised)6
  • Brigham and Women's Hospital3
  • Australian and New Zealand Intensive Care Research Centre2
  • Bloomsbury Institute of Intensive Care Medicine2
  • Center for Sepsis Control and Care2
  • Department of Laboratory Medicine2
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell2

Disease biology

3 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

12 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Sepsis is a systemic inflammatory response syndrome caused by a proven or suspected infection. It can progress to severe sepsis when organ dysfunction develops distant from the infection site, and to septic shock when hypotension persists despite adequate fluid infusion.

Causes

The grounding supports an infectious etiology, with sepsis arising from a proven or suspected infection. It also indicates that bacterial pathogens are relevant in sepsis-associated inflammatory complications, including pneumonia and acute lung injury.

Pathophysiology

Sepsis involves a dysfunctional host response to infection with widespread activation of inflammatory mediators, immune pathways, and the hemostatic system. The literature highlights endothelial dysfunction, altered hemodynamics, cytokine signaling, innate immunity, apoptosis, and cell-free nucleic acids as part of the biological response, with organ dysfunction reflecting this systemic process.

Risk factors

The supplied grounding does not identify specific patient-level risk factors for developing sepsis. It does indicate that infectious stimuli, including bacterial infection and pneumonia, are associated with sepsis and sepsis-related organ injury.

Current standard of care

Management is described at the level of guideline-based care for sepsis and septic shock, with emphasis on hemodynamic support, infection management, adjunctive therapies, metabolic management, and ventilation. The grounding also supports drug therapy and targeted therapeutic approaches, but does not specify individual drug classes beyond general treatment categories.

AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.